Market insights

New ABM Competitions for Enterprises – Action Plan for 2023


The thematic scope of the anticipated grant competitions has been carefully considered and aligns with the current challenges and needs of the medical sector. This bodes well for the future activities of ABM, which is striving to ensure that the funded projects have a strong potential for commercialization and align with the overall development directions of the sector.

Out of the numerous upcoming competitions scheduled in the near future, two specifically target entrepreneurs.

  • Request for Proposals: ABM/2023/4 Medical Device Development or Adaptation for Military Medicine, with emphasis on Battlefield Applications.

    ABM’s activity plans have taken into account the escalating geopolitical tensions in Europe, including Russia’s assault on Ukraine. In light of this, ABM is seeking entities to develop products that offer:

    • Care Under Fire (CUF): Enhancements that increase the chances of survival during active firefights.
    • Tactical Field Care (TFC): Innovations that improve medical care provided in the field, bridging the gap between initial treatment and evacuation.
    • Prolonged Field Care (PFC): Solutions that enable effective medical care over extended periods, addressing the challenges of prolonged missions or delays in evacuation.
    • Tactical Evacuation (TE) Care: Technologies and strategies for providing high-quality medical care during the tactical evacuation of injured personnel from the battlefield.

    The submission of applications in the system is open from June 12, 2023, at 12:00:00 until September 28, 2023, at 12:00:59. The maximum funding amount for the Project cannot exceed 15 million Polish zlotys. The total budget for the competition is PLN 200 million.

  • Competition ABM/2023/5 for the development of new or improved antibiotics, chemotherapeutics, combination preparations, and phage therapies for the treatment of bacterial infections.

    In recent years, a concerning trend has emerged, indicating a rise in the resistance of pathogenic microorganisms to antibiotics. The competition that has been announced directly addresses this phenomenon.

    Funding will be allocated to companies interested in conducting Phase I, II, or III clinical trials for the following:

    • New antibiotics or antibacterial chemotherapeutics.
    • Combination preparations that include multiple antibiotics or combine antibiotics with other compounds.
    • Modifications of existing antibiotics or chemotherapeutics.
    • Phage preparations.

    The call for applications for funding is set to take place in the third quarter of 2023. The competition has a budget of PLN 50 million.

    In concluding ABM’s plans for 2023, it is important to highlight that there are two anticipated grant competitions in which the company can only participate as a consortium member.

  • Competition ABM/2023/2: Implementation of epidemiological studies focusing on multiple diseases, with a budget of PLN 100 million. This competition is scheduled for the second quarter of 2023.
  • Competition ABM/2023/3: Implementation of research experiments involving medical devices and/or medical procedures, specifically in the areas of diagnosis and therapy. The budget for this competition is PLN 200 million, and it is also planned for the second quarter of 2023.
  • Summary

    The thematic scope of the planned competitions offers opportunities for selecting engaging and innovative projects eligible for funding. Since this is just the initial version of ABM’s 2023 plan, we anticipate that future updates will include additional equally appealing grant proposals for entrepreneurs.